Skip to content

The interventional study on the breast enlargement of the mammary gland

The interventional study on the breast enlargement of the mammary gland

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015108
Enrollment
Unknown
Registered
2018-03-07
Start date
2018-03-20
Completion date
Unknown
Last updated
2018-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperplasia of mammary glands

Interventions

treatment group:xiaopiruanfang
control group:rupixiaopian

Sponsors

Gansu Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of Chinese and western medicine; 2. Volunteer to join the group and take the medicine regularly.

Exclusion criteria

Exclusion criteria: 1. The composition and/or supplementary materials of the drug used in this test; 2. Other breast lumps, mastitis, breast cancer, etc. 3. Menstrual cycle or menstrual irregularity, or functional uterine bleeding, or other menstrual diseases; 4. Taking contraceptives or hormone preparations within half a year; 5. Combined with serious primary diseases such as heart, liver, kidney and other important organs and hematopoietic system, such as malignant tumor, AIDS, epilepsy, etc. 6. A combination of nerve, mental disorders, and inability to cooperate or cooperate with others; 7. Pregnancy, lactation women and recent family planning; 8. Participated in other clinical trials within 3 months; 9. It does not meet the inclusion criteria, does not take medicine according to the regulations, cannot judge the effect or the incomplete data affects the curative effect judge.

Design outcomes

Primary

MeasureTime frame
Mammary gland colour to exceed;

Secondary

MeasureTime frame
sex hormone;

Contacts

Public ContactZheng Jun

Gansu Provincial Hospital of TCM

294523586@qq.com+86 13309419836

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026